Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · January 24, 2022

Non-Infectious Uveitis and Myasthenia Gravis Risk With Checkpoint Inhibition

The British Journal of Ophthalmology

 

Additional Info

The British Journal of Ophthalmology
Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database
Br J Ophthalmol 2022 Jan 01;106(1)87-90, T Xia, AJ Brucker, B McGeehan, BL VanderBeek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading